香港六合彩中特网

XClose

香港六合彩中特网 Institute for Innovation and Public Purpose

Menu

Els Torreele

Els Torreele is a Policy Associate at the 香港六合彩中特网 Institute for Innovation & Public Purpose (IIPP).

Els Torreele
Els Torreele has worked for over two decades at the interface of pharmaceutical R&D, human rights and access to medicines, and policy analysis and advocacy around biomedical innovation and access. A bioengineer and PhD in biomedical sciences from the Free University Brussels (VUB), she started to work at the university on innovation policy issues related to R&D agenda-setting, patenting of research, and the commercialization of biotechnology research.听

In 2000, Els Torreele joined the M茅decins Sans Fronti猫res (MSF) Access to Essential Medicines Campaign in its pioneering years as chair of the Drugs for Neglected Diseases Working Group, a multidisciplinary think tank to advance needs-driven R&D for diseases that primarily affect developing countries. A key outcome was the creation in 2003 of the Drugs for Neglected Diseases initiative (), a nonprofit drug development organization which she joined as a founding team member. At DNDi, she led several R&D projects from discovery through clinical trials, which included uncovering and driving the development of fexinidazole, which is now available to patients as the first all-oral treatment for Human African Trypanosomiasis (sleeping sickness).听

In 2009, she joined the Open Society Foundations in New York to lead their Access to Medicines and Innovation work, advancing health and human rights in the area of medicines with a focus on governance, transparency and accountability, and supporting civil society voices and thought leadership in policy making that shapes access to medicines and innovation.听

She returned to MSF in March 2017 as the Executive Director of the Access Campaign, leading for three years a global analysis and advocacy team working to ensure that appropriate medicines, vaccines and diagnostics are developed, available, affordable and adapted to people鈥檚 needs.

She is a Science Honorary Fellow at the Free University of Brussels (VUB) since 2016, and serves on the Board of the AGORA Open Science Trust (, to accelerate the discovery and development of affordable new medicines through open science), since January 2019. She鈥檚 also a member of the Reference Advisory Group of the Health Justice Initiative (), a new public health and law initiative in South Africa addressing the intersection between racial and gender inequality and COVID-19, with a special focus on access to life saving diagnostics, treatment and vaccines (since July 2020). She also served as a Board member for DNDi from 2011-2016. Over the years, she鈥檚 been guest lecturer in different post-graduate courses at the Brussels University, the Antwerp University, the Antwerp Tropical Medicine Institute, the Swiss Tropical Medicine Institute, and Columbia University.

Selected publications

Journal articles
  • Heidari S, Torreele E, G眉lmezoglu AM, Sekalala S, Burke-Shyne N, Landry Chappuis G. A gender-responsive Pandemic Accord is needed for a healthier, equitable future. Lancet, published online 3 Oct 2023.
  • Torreele E, Wolfe D, Kazatchkine M, Sall A, Ruxrungtham K, Fitchett JRA, Kobinger G, Liu J, Vaca-Gonz谩lez C, G贸mez C, Terblanche P, Swaminathan S, Olliaro P, Clark H. From Private Incentives to Public Health Need: 听Rethinking Research and Development for Pandemic Preparedness. Lancet Global Health 2023, 11(10): e1658-e1666. 听
  • Farlow A, Torreele E, Gray G, Ruxrungtham K, Rees H, Prasad S, Gomez C, Sall A, Magalh茫es J, Olliaro P, Terblanche P. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Vaccines. 2023; 11(3):690.
  • Torreele E, McNab C, Adeyi O, Bonnell R, Dhaliwal M, Hassan F, Kazatchkine M, Kim H, Kim J, Quigley HL, Liu J, Nishtar S, Ruxrungtham K, Terblanche P, Todd E, da silva Freire M, Velasquez G, Sirleaf EJ, Clark H. It is time for ambitious, transformational change to the epidemic countermeasures ecosystem. Lancet 2023; 401(10381): 978-982.
  • Angelis A, Polyakov R, Wouters O J, Torreele E, McKee M. High drug prices are not justified by industry鈥檚 spending on research and development BMJ 2023; 380 :e071710听
  • Torreele E, Boum Y 2nd, Adjaho I, Al茅 FGB, Issoufou SH, Harczi G, Okonta C, Olliaro P. Breakthrough treatments for Ebola virus disease, but no access-what went wrong, and how can we do better? Lancet Infect Dis. 2023 Jan 19;S1473-3099(22)00810-6.
  • Torreele E, Kazatchkine M, Liu J, Dybul M, C谩rdenas M, Singh S, Quigley HL, McNab C, Sirleaf EJ, Mazzucato M, Clark H. Stopping epidemics when and where they occur. Lancet. 2023 Jan 12;401(10374):324-8. 听
  • Olliaro P, Torreele E. Global challenges in preparedness and response to epidemic infectious diseases. Molecular Therapy 2022, vol 30(5):听
  • Swaminathan S, P茅coul P, Abdullah H, Christou C, Gray G, IJsselmuiden C, Kieny MP, Mazzucato M, von Messling V, Ogutu B, Reeder R, R酶ttingen J-A, Swarup R, Tanner M, Trindade Lima N, Childs M, Harris A, Torreele E, Moon S. Reboot biomedical R&D in the global public interest. Nature 2022; Vol 602, 10Feb, 209-212.
  • Krikorian G, Torreele E: We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis. HHRJ2021, June, Vol 23/1, pp. 119-127
  • Torreele E, Amon J. Virtual roundtable: Equitable COVID-19 Vaccine Access. HHRJ 2021, June, Vol 23/1, pp. 273-288.
  • Olliaro P, Torreele E, Vaillant M: COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021 2021; 2(7): E279-280.
  • Olliaro P, Torreele E: Managing the risks of making the wrong diagnosis: First, do no harm. Int J Infect Dis. 2021 Apr 9:S1201-9712(21)00315-5. doi: 10.1016/j.ijid.2021.04.004
  • Boum Y II, Ouattara A, Torreele E, Okonte C听: How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa. BMJ Global Health 2021;6:e005306.
  • Murphy听A, Mbau L, McKee M, Hanson K, Torreele E: Can we do for other essential medicines what we are doing for the COVID-19 vaccine? BMJ Global Health 2021;6:e005158.
  • Torreele, E. (2020). . Development.
  • Torreele, E. (2020).听. BMJ. 2020; 370:m3209.
  • Tatay, M. and听Torreele, E. (2019). Ensuring access to life-saving medicines as countries shift from Global Fund support. WHO Bulletin. 2019 May 1;97(5):311-311A.听
  • Balasegaram, M.,听Kolb, P., McKew, J.,听Menon, J., Olliaro, P., Sablinski, T., Thomas, Z., Todd, M. H., Torreele, E., and Wilbanks, J. (2017). An open source pharma roadmap. PLoS Med. 2017 Apr 18;14(4):e1002276.听
  • Brigden, G., Castro, J. L., Ditiu, L., Gray, G., Hanna, D., Low, M., Matsoso, M. P., Perry, G., Spigelman, M., Swaminathan, S., Torreele, E., and Wong, S. (2017). Tuberculosis and antimicrobial resistance - new models of research and development needed. WHO Bulletin. 2017 May 1;95(5):315.听
  • Torreele, E. and听Mazzucato, M. (2016). Fair vaccine pricing please, not random acts of charity. BMJ. 2016 Nov 23;355.
  • Torreele, E., Bourdin Trunz, B., Tweats, D., Kaiser, M., Brun, R., Mazu茅, G., Bray, M. A. and听P茅coul, B. (2010). Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl Trop Dis. 2010, 4(12):e923.
Academic working papers
  • Torreele E, Scataglini M, Greenhill N, Olliaro P. Developing a value proposition for sustainable R&D and availability of Lassa fever therapeutics in West Africa. (2023)
  • De Beer, D.,听Gutwirth, S., Stengers, I. and听Torreele, E. (2020).听Esp茅rer un vaccin鈥ui mais. Article as part of the contribution from Belgian academics to the Exit strategy from Covid lockdown in Belgium (), April 2020
  • Torreele, E. (2018). Yale University Collaboration for Research Integrity and Transparency (CRIT).
  • Torreele, E. (2016).听 Submission to the UN-high Level Panel on Access to Medicines.
Blogs
  • Torreele E, Liu J, Kazatchkine M: Fighting epidemics takes equitable countermeasures. Devex 13 June 2023.
  • Torreele E : Moderna finds a new way to make a killing. Peste magazine 3 Oct 2022.
  • Torreele E. Vaccine equity is not for sale. PLOS Global Public Health Blog 3 May 2022.
  • Torreele E: Global health should not be determined by pharma investors and shareholders. STAT First Opinion May 3, 2022. 听
  • Torreele E. Vaccine equity is not for sale. PLOS Global Public Health Blog 3 May 2022.
  • Torreele E: Serons-nous du bon c么t茅 de l鈥檋istoire avec notre gestion des vaccins covid? Le Soir, 22 May 2021.
  • Torreele E, Kazatchkine M, Mazzucato M: Preparing for the next pandemic requires public health focused industrial policy. BMJ Blog 1 April 2021.
  • Mazzucato M, Ghosh J, and Torreele E: To control the pandemic, it is essential to suspend intellectual property rights on medical products related to covid-19. The Economist 1 April 2021. 听
  • Torreele E & Temmerman M: Van Wie is het coronavaccin听? Van het volk, vinden wij. Opinion De Morgen 8 Jan 2021.
  • Mazzucato M, Li SL, & Torreele E: Designing vaccines for people, not profits. Project Syndicate December 2020.听
  • Torreele E听: Euphorie autour du vaccin Covid pour les pays riches, apartheid vaccinal pour les autres / Carte blanche/La Libre, 28 Dec 2020,
  • Mazzucato, M., Li, H. L., and听Torreele, E. (2021).听听The Daily Maverick.
  • Londeix, P.,听Martin, J., and听Torreele, E. (2020)听 Le Monde.
  • Torreele, E. (2020).听 BMJ Blogs.
  • Hassan, F.听 and听Torreele, E. (2020).听 The Daily Maverick.
  • Torreele, E. (2020).听 STAT, First Opinion.
  • Mazzucato, M. and听Torreele, E. (2019).听. Project Syndicate.
  • Torreele, E. (2020).听 BMJ Blogs.
  • Torreele, E. and Natsis, Y. (2016)听 Eurohealth, 22 (鈥�3)鈥�, 33 - 36. 听 听
  • Torreele, E. (2015).听 PLoS Blogs.
  • Torreele, E. and听Olliaro, P. (2014).听 Al Jazeera, Opinion.
In the media
  • (EOS Wetenschap)
  • (El Pais)
  • (TV5 Monde)
  • 听(France Culture)
  • 听(La Libre)
Media coverage on Els Torreele contribution to the development of fexinidazole, a new sleeping sickness drug developed by DNDi:
  • (Drugs for Neglected Diseases Initiative)
  • 听(Drugs for Neglected Diseases Initiative)
  • (Twitter)
  • 听(El Pais)
  • 听(Huffington Post)
  • 听(The Guardian)
Featured in documentaries:
  • by Frederic Laffont (Arte: original in French, abbreviated version in English)
  • 听(BBC: Rockhopper production)

Contact

Email:听e.torreele@ucl.ac.uk